Arbel Irit Insider Trades

Insider Trading History

Track insider trading activity for Arbel Irit. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $31.6k 41,054 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.6k 30,666 shares
$2.27
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.25M 25,333 shares
$49.35
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Dec 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 25,333 shares
$51.30
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Dec 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.48M 25,333 shares
$58.28
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $125k 162,499 shares
Last Trade
Aug 28, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$371k 6,666 shares
$55.65
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $130k 169,165 shares
Last Trade
Aug 28, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$371k 6,666 shares
$55.65
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $120k 155,833 shares
Last Trade
Aug 28, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$742k 13,332 shares
$55.65
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $0 0 shares
Last Trade
Aug 28, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$371k 6,666 shares
$55.65
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Nov 30, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 25,333 shares
$46.65
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Nov 10, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 25,333 shares
$61.35
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $120k 155,833 shares
Last Trade
Aug 31, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$160k 2,500 shares
$63.90
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $9.24k 12,000 shares
Last Trade
Jul 13, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$812k 12,000 shares
$67.65
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $5.13k 6,667 shares
Last Trade
Feb 26, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$415k 6,667 shares
$62.25
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Jun 22, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$927k 25,333 shares
$36.60
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $19.5k 25,333 shares
Last Trade
Aug 27, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 25,333 shares
$43.50
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $5.13k 6,667 shares
Last Trade
Jun 01, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 6,667 shares
$55.50
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $293k 380,000 shares
Last Trade
Aug 15, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.2M 380,000 shares
$66.34
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $139k 180,000 shares
Last Trade
Apr 19, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.11M 180,000 shares
$50.60
$0.77
Sushi Ginza Onodera
Sushi Ginza Onodera ONDR
Executive VP R&d
Holding Value $0 6,140,000 shares
Last Trade
Nov 16, 2012 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.00
Sushi Ginza Onodera
Sushi Ginza Onodera ONDR
Executive VP R&d
Holding Value $0 2,000,000 shares
Last Trade
Sep 01, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up